～What is an exosome～
Exosomes are “extracellular vesicles” only 1/10,000th of a millimeter in diameter. Exosomes are small intracellular information carriers that are known to be secreted by almost all cells. Exosomes contain microRNAs, which were the focus of attention in the vaccine against the COVID-19.
Cells use the microRNAs in exosomes to exchange information with each other.

～Cancer Risk Test with the potential exosomes～
In the past, time-consuming and labor-intensive examinations such as CT imaging and endoscopy were common.
However, two revolutionary new tests can now read “exosomes,” the intracellular information carriers in blood, and easily determine the risk of pancreatic and other gastrointestinal cancers

This type of blood test enables to find early stages of Pancreas Cancer compared to diagonostic image testing with lower stress for the body

The Pancreas located behind the stomach area is an important organ to secrete pancretic fluids for digestion and insulin secreting our hormones.
Pancreatic Cancer develops deep within our body with mild symptoms which makes it hard to detect early stage.Compared to other cases of Cancer, Pancreatic cancer has the lowest survival rate calculated of 5 years,and cases over 30,000 have lost their lives.
Treatment for Pancreas Cancer is oftenly is too late after symptoms have appeared.The best solution would be to take examinations on a regular basis.

Exosomes that are secreted from Cancer cells are calculated within markers ’Panc 1’ and ‘Panc 2’ to determine the risk of Pancreas Cancer

Measuring the surface of exosomes and specific protein within the existing 500 types

Panc1：

(+) indicates a higher risk of Pancreatic Cancer than average (-) indicates normal level Pancreatic cancer than average (-) indicates normal level
Other related diseases such as Diabetes, pancreatitis, pancreatic cysts, pancreatic stone disease, heredity (HBOC, Lynch syndrome), lifestyle-related diseases may appear (+)

Panc2：

A general marker that indicates (+) when the risk of cancer, including pancreatic cancer, and non-cancer diseases is higher than that of healthy individuals.

Enables to distinguish between pancreatitis and pancreatic cancer

We are in generation when 2 in 1 can get cancer.Detection of gastrointestinal cancers, which account for about half of all cancers, at a stage of unwawareness.

Cancer is the leading cause of death among Japanese people. Cancer is a disease that anyone can get Cancer of the digestive organs accounts for about half of all cancers

Cancer affects many people, and the most important thing is early detection!
With the development of medical science, the best treatment options are available as long as it is detected early.Cancer is now a disease that can be conquered with a high possibility of cure.
However, when Gastrointestinal Cancers are detected after symptoms appear, they are often too late and difficult to cure.

To ensure that you lead a healthy and fulfilling life, even if you do not have any symptoms, It is very important to have regular checkups and early detection even if you do not have any symptoms.

The test measures ”GI-1”, a unique marker on exosomes secreted by cancer cells, to determine the risk of developing gastrointestinal cancers. It measures specific proteins on the surface of exosomes and within 500 different types of exosomes.

A single blood sample can measure the risk of 5 types of cancer: stomach cancer, esophagus cancer, colon cancer, gall bladder cancer, and liver cancer.

Eri Clinic Omotesando has Dr. Takahiro Ochiya as its advisor, and has formed a business alliance with a laboratory that possesses the most advanced cell culture processing technology. We provide stem cell therapy and immunotherapy, which have been very well received.

■ Dr. Takahiro Ochiya Profile

Professor of Tokyo Medical University / medical doctor
Head of Molecular Cell Therapy Research Department, National Cancer Center Research Institute

In 2017, he was selected by the Nobel Committee as one of the 10 most notable researchers in the world, the only Japanese researcher to be selected
In 2022, Clarivate Analytics announced the most influential scientific researchers and their institutions in the Highly Cited Researchers, and Prof. Takahiro Ochiya was selected. He was selected as one of the top 1% researchers in the world for four consecutive years.